SNCA

Chr 4AD

synuclein alpha

Also known as: NACP, PARK1, PARK4, PD1

Alpha-synuclein regulates synaptic vesicle trafficking and neurotransmitter release, acts as a molecular chaperone for SNARE proteins, and modulates dopamine transporter activity. Mutations cause autosomal dominant Parkinson disease and Lewy body dementia, typically with adult onset affecting movement and cognition. The gene is highly constrained against loss-of-function variants (pLI 0.88, LOEUF 0.43), reflecting its essential role in neuronal function.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 0.433 OMIM phenotypes
Clinical SummarySNCA
🧬
Gene-Disease Validity (ClinGen)
Parkinson disease · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.88) — some intolerance to loss-of-function variants.
💊
Clinical Trials
8 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — SNCA
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.43LOEUF
pLI 0.883
Z-score 2.45
OE 0.00 (0.000.43)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.46Z-score
OE missense 0.85 (0.691.05)
61 obs / 72.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.00 (0.000.43)
00.351.4
Missense OE0.85 (0.691.05)
00.61.4
Synonymous OE1.30
01.21.6
LoF obs/exp: 0 / 7.0Missense obs/exp: 61 / 72.0Syn Z: -1.14
DN
0.6937th %ile
GOF
0.82top 10%
LOF
0.4529th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFThe pathogenic A53T and A30P alpha-synuclein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degradation and that of other substrates. These findings may underlie the toxic gain-of-function by the mutants.PMID:15333840

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SNCA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Parkinson DiseaseNervous System DisorderNeurodegenerative Diseases

Molecular and Functional Imaging in Monogenic PD.

RECRUITING
NCT05518617University of ExeterStarted 2022-07-01
Positron Emission Tomography (PET) scan using DASB tracer
Parkinson's Disease (PD)

Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)

RECRUITING
NCT07142044Phase PHASE1, PHASE2EicOsis Human Health Inc.Started 2025-10
EC5026 oral tabletPlacebo
Parkinson Disease

Chinese PD-SNCA Registry

RECRUITING
NCT03523052Xiangya Hospital of Central South UniversityStarted 2017-02-01
Parkinson'sParkinson DiseaseParkinson's Disease

Longitudinal Investigation of I2BS in PD

RECRUITING
NCT05516719University of ExeterStarted 2021-11-01
Positron Emission Tomography (PET) scan using BU99008 tracerFP-CIT Single-photon Emission Computed Tomography (SPECT) scanMagnetic Resonance Imaging (MRI) Scan
Parkinson DiseaseParkinson'sParkinson's Disease

Serotonin Release in Premotor and Motor PD

RECRUITING
NCT05516732University of ExeterStarted 2022-07-01
Positron Emission Tomography (PET) scan using CIMBI-36 tracerMagnetic Resonance Imaging (MRI) ScanPositron Emission Tomography (PET) scan using DASB tracer
Parkinson Disease

Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease

ACTIVE NOT RECRUITING
NCT04553185University of ExeterStarted 2018-11-28
Study procedure
Parkinson's Disease (PD)GBA1 Parkinson DiseaseREM Sleep Behavior Disorder (iRBD)

Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging

NOT YET RECRUITING
NCT07474779Phase NAUniversity of PaviaStarted 2026-05-11
brain imagingblood drawSkin biopsy
Restless Leg Syndrome (RLS)

Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment

RECRUITING
NCT06726785HBC Immunology IncStarted 2025-07-01
Clinical Literature
Open Research Assistant →